CCEL Q3 2018 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q3 2018 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+14.1% YoY

Gross Profit

$5M68.4% margin

Operating Income

$920,12211.7% margin

Net Income

$244,9843.1% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+20.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$55,412

Balance Sheet

Total Assets

$43M

Total Liabilities

$52M

Stockholders' Equity

-$10M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+14.1%
Gross Profit	$5M	$5M	+9.5%
Operating Income	$920,122	$1M	-36.6%
Net Income	$244,984	$652,019	-62.4%

Revenue Segments

Umbilical Cord Blood And Cord Tissue Stem Cell Service

$8M49%

Processing and Storage Fees

$7M46%

Licensee And Royalty Income Recognition

$539,2863%

Public Banking

$65,5750%

Public Cord Blood Banking

$65,5750%

Prepacyte-CB

$29,3080%

Product

$29,3080%